raf

Stock trader always looking for scalp or swing trades in all sectors.

[raf @recervan]

@SpurgeonsCigar Great places to visit, just leave your jewelry home and pack your Glock

[raf @recervan]

Fed meeting today at 2:00PM EST Traders brace for least predictable Fed meeting in years | Reuters https://t.co/7QJJYwdjTS

[raf @recervan]

@WillManso Good thing she looks like her mom Will. Go Canes!

[raf @recervan]

$WISH up 37% in premarket…ContextLogic stock jumps as it announces $173M sale of Wish to Qoo10 | Seeking Alpha https://t.co/dJBTnLEt9A

[raf @recervan]

$HKIT up 510% in premarket…
Hitek Global (NASDAQ:HKIT) stock is rocketing higher on Thursday despite a lack of news from the company and heavy trading of its shares.

[raf @recervan]

$ARM up 28% in premarket…
Arm shares soar after chip designer gives strong forecast boosted by AI @CNBC https://t.co/FIRVQD5XuK

[raf @recervan]

$MOTS up 48% in premarket…
Motus GI Holdings (MOTS) Reports Publication of Positive Results from a European Study of the Second Generation Pure-Vu System https://t.co/2eQQjXvWbj

[raf @recervan]

$ITRM up 62% in premarket…
Iterum Therapeutics (ITRM) Reports Positive Topline Results from its Phase 3 REASSURE Trial of Oral Sulopenem https://t.co/KVDw0MJKz2

[raf @recervan]

$CMND up 36% in premarket…Clearmind Medicine Completed Type A Meeting with the FDA completed https://t.co/5ClyioVI3f

[raf @recervan]

$ABVC up 76% in premarket…
ABVC BioPharma up on receiving $460 mln worth shares under licensing deal https://t.co/gzKNVQvdyn

[raf @recervan]

$MGTX up 23% in premarket…MeiraGTx Announces Asset Purchase Agreement Involving its https://t.co/XREa1w4P8j

[raf @recervan]

$HOOK up 72% in premarket…HOOKIPA Pharma Announces $21.25 Million Equity Investment from Gilead Sciences | Hookipa Pharma Inc. https://t.co/fybzgXqjco

[raf @recervan]

$CGEN up 200% in premarket…Compugen stock rockets on anti-tumor drug deal with Gilead - MarketWatch https://t.co/JYwiRSOBr7

[raf @recervan]

$VRCA up 12% in premarket…
Verrica Pharmaceuticals’ Development and Commercialization https://t.co/ptAY0q8uJo

[raf @recervan]

$MNMD up 16% in premarket…MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder https://t.co/yhepC30TgZ

[raf @recervan]

$STTK up 97% in premarket…Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine https://t.co/XcFHFvyXQb

[raf @recervan]

$CCCC up 69% in premarket…
C4 Therapeutics Announces License and Research Collaboration with Merck to Discover and Develop Degrader-Antibody Conjugates (DACs) – C4 Therapeutics, Inc. https://t.co/EdG502XzwG

[raf @recervan]

$TCRX up 12% in premarket…
TScan Therapeutics (TCRX) Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 https://t.co/YfiRGCZhBd

[raf @recervan]

$PSTX up 25% in premarket…
Poseida Therapeutics (PSTX) Presents Positive Early Results from its Phase 1 Trial of P-BCMA-ALLO1 https://t.co/aTURVpp9Hk

[raf @recervan]

$CURV up 32% in premarket…
Torrid Holdings Shares Rise 15% After Lifting FY23 Revenue Guidance - MarketWatch https://t.co/YI90GPvNeb